Jack Levine - Jun 2, 2023 Form 4 Insider Report for EzFill Holdings Inc (EZFL)

Role
Director
Signature
/s/ Jack Levine
Stock symbol
EZFL
Transactions as of
Jun 2, 2023
Transactions value $
$0
Form type
4
Date filed
6/6/2023, 04:15 PM
Previous filing
Dec 29, 2022
Next filing
Jun 27, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EZFL Common Stock Award $0 +58.8K +110.08% $0.00 112K Jun 2, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares will fully vest in 12 months from the grant date. Should the Reporting Person leave the Issuer's board of directors prior to vesting, the Reporting Person will be awarded a grant on a pro rata basis based on the time spent as a member of the board of directors. The number of shares is based on $130,000 per the Issuer's director compensation agreement with the Reporting Person and the closing price $2.21 on June 2, 2023.
F2 The Reporting Person holds 23,252 shares of Common Stock through an entity Cameo Life Sciences Investments, LLC. The number of shares reflects a one-for-eight reverse split effective on April 27, 2023.
F3 Granted pursuant to the EzFill Holdings, Inc. 2023 Equity Incentive Plan.